BioCentury
ARTICLE | Clinical News

Lenti-D gene therapy: Additional Phase I data

June 7, 2010 7:00 AM UTC

Additional data from a French Phase I trial in 3 patients with ALD showed that Lenti-D gene therapy led to continued stable expression of ALD protein, with expression in 10-15% of monocytes, and disea...